COVID-19: Start with the nose

Brian Lipworth; Rory Chan; Chris RuiWen Kuo

doi:10.1016/j.jaci.2020.06.038

COVID-19: Start with the nose

Brian Lipworth (Lead / Corresponding author), Rory Chan, Chris RuiWen Kuo

Molecular and Clinical Medicine

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1214
Number of pages	1
Journal	Journal of Allergy and Clinical Immunology
Volume	146
Issue number	5
Early online date	14 Aug 2020
DOIs	https://doi.org/10.1016/j.jaci.2020.06.038
Publication status	Published - Nov 2020

Access to Document

10.1016/j.jaci.2020.06.038Licence: Elsevier User Licence

Cite this

@article{7f80698ee7e846dda2f84309bd3f08be,

title = "COVID-19: Start with the nose",

author = "Brian Lipworth and Rory Chan and Kuo, {Chris RuiWen}",

note = "Funding Information: Disclosure of potential conflict of interest: B. J. Lipworth reports grants and personal fees from AstraZeneca, Teva, Chiesi, and Meda; personal fees from Cipla and Glenmark, relevant to the submitted work; personal fees from Lupin and grants and personal fees from Sanofi, outside of the submitted work; and that his son is an employee of AstraZeneca. C. R. Kuo reports personal fees from AstraZeneca and personal fees from Chiesi, relevant to the submitted work. R. Chan reports no relevant conflicts of interest. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = nov,

doi = "10.1016/j.jaci.2020.06.038",

language = "English",

volume = "146",

pages = "1214",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - COVID-19

T2 - Start with the nose

AU - Lipworth, Brian

AU - Chan, Rory

AU - Kuo, Chris RuiWen

N1 - Funding Information: Disclosure of potential conflict of interest: B. J. Lipworth reports grants and personal fees from AstraZeneca, Teva, Chiesi, and Meda; personal fees from Cipla and Glenmark, relevant to the submitted work; personal fees from Lupin and grants and personal fees from Sanofi, outside of the submitted work; and that his son is an employee of AstraZeneca. C. R. Kuo reports personal fees from AstraZeneca and personal fees from Chiesi, relevant to the submitted work. R. Chan reports no relevant conflicts of interest. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85090061571&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2020.06.038

DO - 10.1016/j.jaci.2020.06.038

M3 - Letter

C2 - 32828591

VL - 146

SP - 1214

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5

ER -

COVID-19: Start with the nose

Access to Document

Other files and links

Cite this